Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OSCARE: Celecoxib for Hip OA Progression
NCT00163241Phase 3Terminated
- Sponsor
- Viatris
- Start
- Jun 2004
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in osteoarthritis of the hip comparing Celecoxib with Placebo (2 arms). Primary endpoint: Change in minimal Joint Space Width of the index hip at 24 months. Started Jun 2004; status: terminated.
02
Drugs
celecoxib
03
Conditions
osteoarthritis of the hip
Beyond the preview
Go deeper on NCT00163241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00163241.